Stockscreener 앱 받기
0.81%
전일 마감가:
$281.22
열려 있는:
$281.57
하루 거래량:
399.38K
Relative Volume:
0.13
시가총액:
$151.07B
수익:
$34.13B
순이익/손실:
$5.93B
주가수익비율:
25.47
EPS:
10.96
순현금흐름:
$10.92B
1주 성능:
-1.47%
1개월 성능:
-5.25%
6개월 성능:
-12.64%
1년 성능:
-10.40%
1일 변동 폭
$276.09
$281.97
1주일 범위
$275.19
$292.00
52주 변동 폭
$253.30
$346.85
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
278.80 | 151.07B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
824.33 | 739.75B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
155.15 | 370.90B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
196.79 | 340.25B | 57.37B | 4.20B | 17.83B | 2.35 |
|
NVO
Novo Nordisk Adr
|
69.18 | 277.97B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
113.44 | 222.45B | 53.22B | 12.86B | 14.85B | 6.39 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Amgen (NASDAQ:AMGN) Releases Earnings Results - MarketBeat
AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth - TradingView
Alteri Wealth LLC Buys Shares of 11,903 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Red Biotechnology Market to Witness Remarkable Growth with - openPR.com
Marshall Wace LLP Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PDT Partners LLC Has $1.51 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bison Wealth LLC Reduces Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
The Manufacturers Life Insurance Company Sells 27,512 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Mercer Global Advisors Inc. ADV Buys Shares of 116,537 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen: Reducing My Price Target, Reiterate Buy After A Solid Q1 - Seeking Alpha
Meiji Yasuda Life Insurance Co Has $6.05 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
California State Teachers Retirement System Sells 23,730 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Trimmed by Public Employees Retirement Association of Colorado - MarketBeat
Northern Trust Corp Has $1.68 Billion Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,826 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Marshall & Sterling Wealth Advisors Inc. - MarketBeat
Beacon Pointe Advisors LLC Lowers Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Arrow Financial Corp Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,825 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Westbourne Investments Inc. - MarketBeat
Voleon Capital Management LP Invests $1.52 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Nebula Research & Development LLC Purchases New Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. Reports Strong Growth Amid Challenges - TipRanks
Amgen (AMGN) Receives a Revised Price Target from UBS Analyst | - GuruFocus
Amgen (AMGN) Receives a Revised Price Target from UBS Analyst | AMGN Stock News - GuruFocus
Robots of Amgen - Amgen
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data - Benzinga
Amgen (AMGN): RBC Capital Maintains Rating, Lowers Price Target | AMGN Stock News - GuruFocus
Amgen (NasdaqGS:AMGN) Reports Strong Q1 Earnings With Revenue Increase To US$8 Billion - simplywall.st
Amgen’s Stelara biosimilar gets off to fast start - BioPharma Dive
Citigroup Adjusts Price Target on Amgen to $300 From $290 - marketscreener.com
Cantor Fitzgerald maintains neutral on Amgen stock, target at $305 - Investing.com
Cantor Fitzgerald maintains neutral on Amgen stock, target at $305 By Investing.com - Investing.com UK
Amgen Unusual Options Activity For May 02 - Nasdaq
Amgen (AMGN) Price Target Reduced by UBS Analyst | AMGN Stock News - GuruFocus
Amgen (AMGN) Surges After Beating Q1 Earnings Expectations - GuruFocus
Strong first-quarter product sales for Amgen - The Pharma Letter
Parvin Asset Management LLC Invests $1.46 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Street View: Investor focus still on Amgen's weight-loss drug candidate - TradingView
UBS Adjusts Price Target on Amgen to $315 From $319, Maintains Neutral Rating - marketscreener.com
Navigoe LLC Makes New $390,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth - TradingView
Comerica Bank Decreases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bridgewealth Advisory Group LLC Makes New $417,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Lowered by Becker Capital Management Inc. - MarketBeat
RBC Trims Price Target on Amgen to $320 From $324, Keeps Outperform Rating - marketscreener.com
Amgen’s Aflibercept Starts Strong As Regeneron Counts Cost Of Eylea Competition - insights.citeline.com
Amgen (AMGN) Surpasses Expectations with Strong Q1 Performance - GuruFocus
Amgen Inc (AMGN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Pricing Challenges - Yahoo Finance
Coldstream Capital Management Inc. Reduces Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Oxford Asset Management LLP Takes $1.25 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
암젠 주식 (AMGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 19 '25 |
Option Exercise |
156.35 |
8,711 |
1,361,965 |
80,257 |
| Santos Esteban | EVP, Operations |
Feb 19 '25 |
Sale |
292.84 |
8,711 |
2,550,903 |
71,546 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Option Exercise |
156.35 |
8,711 |
1,361,965 |
70,858 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 21 '25 |
Sale |
304.44 |
25,225 |
7,679,524 |
36,922 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Sale |
293.22 |
8,711 |
2,554,224 |
62,147 |
0.83%
자본화:
|
볼륨(24시간):